Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
---|
07/03/2002 | CN1357038A Combination of lactic acid bacteria and its use for prevention and/or treatment of infections and inflammatory conditions |
07/03/2002 | CN1357001A Novel ribose-substituted aromatic amides, method for prodn. and use thereof as medicaments |
07/03/2002 | CN1356911A Method for treatment of fibrosis using antagonist of integrin alpha-4 subunit |
07/02/2002 | US6414148 Produce antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals |
07/02/2002 | US6414126 C-aryl glucoside SGLT2 inhibitors and method |
07/02/2002 | US6414032 Anti-infective compositions for treating disordered tissue such as cold sores |
07/02/2002 | US6414022 Cyclopentane(ENE)heptenoic or heptenoic acids and derivatives thereof useful as therapeutic agents |
07/02/2002 | US6414021 Vision defects |
07/02/2002 | US6414011 Central nervous system disorders |
07/02/2002 | US6413996 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
07/02/2002 | US6413965 Selective cox-2 and an aldose reductase inhibitor; neuropathy, nephropathy, retinopathy and cardiomyopathy; avoiding side effects such as gastric and renal toxicity |
07/02/2002 | US6413963 Alpha, beta-integrin inhibitors used in the treatment of multiple sclerosis, atherosclerosis, asthma and inflammatory bowel disease |
07/02/2002 | US6413958 For treatment/prevention of infection of herpes simplex virus, varicella zoster virus, human cytomegalovirus, or epstein-barr virus; enzyme inhibitors |
07/02/2002 | US6413955 1,8-naphthyridines or 5-thio-1,8-naphthyridines or 5-oxo-1,8-naphthyridines; bone resorption, osteoporosis, vascular rest-enosis, diabetic retinopathy, macular degeneration, angio-genesis, atherosclerosis, inflammatory arthritis, cancer |
07/02/2002 | US6413932 Tek antagonists comprising soluble tek extracellular binding domain |
07/02/2002 | US6413731 Methods of screening for compounds which bind to a human SNORF36A receptor |
07/02/2002 | US6413540 For eyes |
07/02/2002 | US6413527 Nanoemulsion based on alkyl ether citrates and its uses in the cosmetics, dermatological, pharmacological and/or ophthalmological fields |
07/02/2002 | CA2064478C Ophthalmic composition |
07/02/2002 | CA2022119C Substituted aromatic sulfonamides as antiglaucoma agents |
06/27/2002 | WO2002050289A1 Methods for the production of multimeric proteins, and related compositions |
06/27/2002 | WO2002050287A2 Multifunctional protease inhibitors and their use in treatment of disease |
06/27/2002 | WO2002050255A2 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof |
06/27/2002 | WO2002050097A2 Anti-allergic complex molecules |
06/27/2002 | WO2002050070A2 Piperidine derivatives as subtype selective n-methyl-d-aspartate antagonists |
06/27/2002 | WO2002050043A1 Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof |
06/27/2002 | WO2002050039A1 Urea and urethane derivatives as integrin inhibitors |
06/27/2002 | WO2002050033A1 Benzo(f) isoindol derivatives and their use as ep4 receptor ligands |
06/27/2002 | WO2002050032A1 Naphthalene derivatives which bind to the ep4 receptor |
06/27/2002 | WO2002050031A1 Indole derivatives |
06/27/2002 | WO2002050021A1 Nitric oxide synthase inhibitor phosphate salt |
06/27/2002 | WO2002049677A1 Lentiviral vector-mediated gene transfer and uses thereof |
06/27/2002 | WO2002049654A1 Shark meat extract |
06/27/2002 | WO2002049651A1 Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidines and antithrombotic agents, calcium-antagonists, prostaglandins or prostaglandin derivatives |
06/27/2002 | WO2002049650A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives |
06/27/2002 | WO2002049649A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2) |
06/27/2002 | WO2002049646A1 Therapeutic combination of amlodipine and benazepril/benazeprilat |
06/27/2002 | WO2002049645A1 Therapeutic combination of amlodipine and benazepril |
06/27/2002 | WO2002049634A2 Dissociated glucocorticoid receptor antagonists for the treatment of clucocorticoid associated side-effect |
06/27/2002 | WO2002049624A2 Novel pharmaceutical compositions based on anticholinergic agents and dopamine agonists |
06/27/2002 | WO2002049615A2 Artificial tear composition containing a combination of three demulcents |
06/27/2002 | WO2002049614A2 Intraocular irrigating solution having improved flow characteristics |
06/27/2002 | WO2002049612A2 Hypertonic ophthalmic irrigation solution adapted for use in lasik surgery |
06/27/2002 | WO2002049574A2 Method for curing child's and adolescent myopia using a spiruline preparation |
06/27/2002 | WO2002022168A3 Vaccine against streptococcus pneumoniae |
06/27/2002 | WO2002022167A3 Vaccine against streptococcus penumoniae |
06/27/2002 | WO2002020566A3 NOVEL MMP-2 DERIVATIVES FOR USE AS INHIBITORS OF INTEGRIN αVβ¿3? |
06/27/2002 | WO2002008231A3 Biologically active macrolides, compositions, and uses thereof |
06/27/2002 | WO2001092267A3 Dihydropyridine compounds for the inhibition of calcium-influx |
06/27/2002 | WO2001074330A3 Method for treating dry eye |
06/27/2002 | WO2001073025A3 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
06/27/2002 | US20020082417 Compound for use in the treatment of vision defects and chronic obstructive pulmonary diseases |
06/27/2002 | US20020082388 Polypeptide for use in the treatment, diagnosis and prevention of cancer, nervous system and developmental disorders |
06/27/2002 | US20020082292 Agonists of peroxisome proliferator activated receptor (PPAR) alpha and/or gamma |
06/27/2002 | US20020082286 3-heteroatom substituted and two carbon homologs of 15-HETE and methods of use |
06/27/2002 | US20020082278 Use to treat allergy, nasal congestion, inflammatory and central nervous system-related diseases |
06/27/2002 | US20020082272 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
06/27/2002 | US20020082266 Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore |
06/27/2002 | US20020082231 Utilizing ratC polypeptides to screen for antibacterial compounds |
06/27/2002 | US20020081659 Nucleic acids, proteins and antibodies |
06/27/2002 | US20020081623 Chemotactic cytokine |
06/27/2002 | US20020081299 Hair cell disorders |
06/27/2002 | US20020081290 Protein kinase homologs |
06/27/2002 | CA2436699A1 Piperidine derivatives as subtype selective n-methyl-d-aspartate antagonists |
06/27/2002 | CA2432879A1 Anti-allergic complex molecules |
06/27/2002 | CA2432760A1 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof |
06/27/2002 | CA2432638A1 Therapeutic combination of amlodipine and benazepril |
06/27/2002 | CA2432315A1 Methods for the production of multimeric proteins, and related compositions |
06/27/2002 | CA2432301A1 Lentiviral vector-mediated gene transfer and uses thereof |
06/27/2002 | CA2432282A1 Therapeutic combination of amlodipine and benazepril/benazeprilat |
06/27/2002 | CA2431147A1 Pharmaceutical formulation comprising thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2) |
06/27/2002 | CA2431077A1 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives |
06/27/2002 | CA2431074A1 Pharmaceutical formulation comprising thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (1) |
06/27/2002 | CA2430973A1 Multifunctional protease inhibitors and their use in treatment of disease |
06/27/2002 | CA2430595A1 Dissociated glucocorticoid receptor antagonists for the treatment of glucocorticoid associated side-effect |
06/27/2002 | CA2423331A1 Shark meat extract |
06/26/2002 | EP1216707A1 New therapeutic uses of a SMR-1-peptide |
06/26/2002 | EP1216309A2 Methods for targeting rna molecules |
06/26/2002 | EP1216257A1 Compounds for the treatment of ischemia |
06/26/2002 | EP1216247A1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
06/26/2002 | EP1216245A1 Pharmaceutically active sulfonyl hydrazide derivatives |
06/26/2002 | EP1216241A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
06/26/2002 | EP1216238A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
06/26/2002 | EP1216234A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
06/26/2002 | EP1216230A2 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
06/26/2002 | EP1216046A2 Novel combination of loteprednol and antihistamines |
06/26/2002 | EP1216037A2 Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents |
06/26/2002 | EP1051155B1 Nasal solutions |
06/26/2002 | EP0820441B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS |
06/26/2002 | CN1355799A 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
06/26/2002 | CN1355701A Urea substituted imidazoquinolines |
06/26/2002 | CN1355021A Percutaneous medicine of strychnine (toxiferine or securinine) and salt thereof |
06/26/2002 | CN1086590C Eye drops contg. sodium hyaluronate and preparing method thereof |
06/25/2002 | US6410791 Salbutamol; respiratory system disorders |
06/25/2002 | US6410780 C11 oxymyl and hydroxylamino prostaglandins useful as medicaments |
06/25/2002 | US6410599 Mixture of benzalkonium chloride, water and isopropanol |
06/25/2002 | US6410591 Vision defects |
06/25/2002 | US6410589 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
06/25/2002 | US6410583 Prostaglandin antagonist |
06/25/2002 | US6410553 Benzosulfones and related compositions and methods |